19-57908853-A-G
Variant names:
Variant summary
Our verdict is Benign. Variant got -21 ACMG points: 0P and 21B. BP4_StrongBP6_Very_StrongBP7BS1BS2
The NM_152475.3(ZNF417):c.1425T>C(p.Asn475Asn) variant causes a synonymous change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00253 in 1,613,584 control chromosomes in the GnomAD database, including 94 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★).
Frequency
Genomes: 𝑓 0.013 ( 53 hom., cov: 32)
Exomes 𝑓: 0.0014 ( 41 hom. )
Consequence
ZNF417
NM_152475.3 synonymous
NM_152475.3 synonymous
Scores
2
Clinical Significance
Conservation
PhyloP100: -8.83
Genes affected
ZNF417 (HGNC:20646): (zinc finger protein 417) Predicted to enable DNA-binding transcription factor activity, RNA polymerase II-specific and RNA polymerase II cis-regulatory region sequence-specific DNA binding activity. Predicted to be involved in regulation of transcription by RNA polymerase II. Predicted to be active in nucleus. [provided by Alliance of Genome Resources, Apr 2022]
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Benign. Variant got -21 ACMG points.
BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.94).
BP6
Variant 19-57908853-A-G is Benign according to our data. Variant chr19-57908853-A-G is described in ClinVar as [Benign]. Clinvar id is 774743.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BP7
Synonymous conserved (PhyloP=-8.83 with no splicing effect.
BS1
Variant frequency is greater than expected in population afr. gnomad4 allele frequency = 0.0134 (2034/151708) while in subpopulation AFR AF= 0.0464 (1919/41330). AF 95% confidence interval is 0.0447. There are 53 homozygotes in gnomad4. There are 935 alleles in male gnomad4 subpopulation. Median coverage is 32. This position pass quality control queck.
BS2
High Homozygotes in GnomAd4 at 53 AR gene
Transcripts
RefSeq
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
ZNF417 | ENST00000312026.6 | c.1425T>C | p.Asn475Asn | synonymous_variant | Exon 3 of 3 | 1 | NM_152475.3 | ENSP00000311319.4 | ||
ZNF417 | ENST00000595559.1 | c.1422T>C | p.Asn474Asn | synonymous_variant | Exon 3 of 3 | 1 | ENSP00000472272.1 | |||
ENSG00000269476 | ENST00000602124.1 | n.34+3207T>C | intron_variant | Intron 3 of 5 | 3 | ENSP00000470782.1 | ||||
ZNF417 | ENST00000594396.1 | c.106+3207T>C | intron_variant | Intron 1 of 2 | 3 | ENSP00000472352.1 |
Frequencies
GnomAD3 genomes AF: 0.0134 AC: 2036AN: 151590Hom.: 53 Cov.: 32
GnomAD3 genomes
AF:
AC:
2036
AN:
151590
Hom.:
Cov.:
32
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD3 exomes AF: 0.00341 AC: 858AN: 251446Hom.: 10 AF XY: 0.00247 AC XY: 335AN XY: 135892
GnomAD3 exomes
AF:
AC:
858
AN:
251446
Hom.:
AF XY:
AC XY:
335
AN XY:
135892
Gnomad AFR exome
AF:
Gnomad AMR exome
AF:
Gnomad ASJ exome
AF:
Gnomad EAS exome
AF:
Gnomad SAS exome
AF:
Gnomad FIN exome
AF:
Gnomad NFE exome
AF:
Gnomad OTH exome
AF:
GnomAD4 exome AF: 0.00140 AC: 2053AN: 1461876Hom.: 41 Cov.: 81 AF XY: 0.00123 AC XY: 892AN XY: 727238
GnomAD4 exome
AF:
AC:
2053
AN:
1461876
Hom.:
Cov.:
81
AF XY:
AC XY:
892
AN XY:
727238
Gnomad4 AFR exome
AF:
Gnomad4 AMR exome
AF:
Gnomad4 ASJ exome
AF:
Gnomad4 EAS exome
AF:
Gnomad4 SAS exome
AF:
Gnomad4 FIN exome
AF:
Gnomad4 NFE exome
AF:
Gnomad4 OTH exome
AF:
GnomAD4 genome AF: 0.0134 AC: 2034AN: 151708Hom.: 53 Cov.: 32 AF XY: 0.0126 AC XY: 935AN XY: 74158
GnomAD4 genome
AF:
AC:
2034
AN:
151708
Hom.:
Cov.:
32
AF XY:
AC XY:
935
AN XY:
74158
Gnomad4 AFR
AF:
Gnomad4 AMR
AF:
Gnomad4 ASJ
AF:
Gnomad4 EAS
AF:
Gnomad4 SAS
AF:
Gnomad4 FIN
AF:
Gnomad4 NFE
AF:
Gnomad4 OTH
AF:
Alfa
AF:
Hom.:
Bravo
AF:
Asia WGS
AF:
AC:
8
AN:
3478
EpiCase
AF:
EpiControl
AF:
ClinVar
Significance: Benign
Submissions summary: Benign:2
Revision: criteria provided, multiple submitters, no conflicts
LINK: link
Submissions by phenotype
not provided Benign:2
-
Breakthrough Genomics, Breakthrough Genomics
Significance: Benign
Review Status: criteria provided, single submitter
Collection Method: not provided
- -
Dec 31, 2019
Labcorp Genetics (formerly Invitae), Labcorp
Significance: Benign
Review Status: criteria provided, single submitter
Collection Method: clinical testing
- -
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
CADD
Benign
DANN
Benign
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at